Inhalation by design: novel tertiary amine muscarinic M₃ receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease. (Q39483819)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Inhalation by design: novel tertiary amine muscarinic M₃ receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease. |
scientific article |
Statements
Inhalation by design: novel tertiary amine muscarinic M₃ receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease (English)
Paul A Glossop
Christine A L Watson
David A Price
Mark E Bunnage
Donald S Middleton
Anthony Wood
Kim James
Dannielle Roberts
Ross S Strang
Michael Yeadon
Christelle Perros-Huguet
Nicholas P Clarke
Michael A Trevethick
Ian Machin
Emilio F Stuart
Steven M Evans
Anthony C Harrison
David A Fairman
Balaji Agoram
Jane L Burrows
Craig K Fulton
Barry R Dillon
David A Entwistle
Fiona J Spence
20 September 2011